FDA Rejects Apricus Biosciences' Erectile Dysfunction Cream Vitaros Post author:Sam Post published:February 15, 2018 Post category:BioPharma The CRL indicates that the FDA cannot approve the NDA for Vitaros in its present form. Source: BioSpace You Might Also Like Final Surviving Claims In MiMedx Patent Infringement Lawsuit Against Scheduled To Go To Trial In January 2018 October 9, 2017 <b>Apceth Biopharma</b> Appoints <b>Dusan Kosijer</b> As Chief Financial Officer May 30, 2017 <b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017
Final Surviving Claims In MiMedx Patent Infringement Lawsuit Against Scheduled To Go To Trial In January 2018 October 9, 2017
<b>MaxWell Biosciences</b> CEO Faces Backlash After Openly Discriminating Against Men September 26, 2017